iBio (IBIO)
(Delayed Data from AMEX)
$2.63 USD
+0.01 (0.38%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $2.62 -0.01 (-0.38%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum D VGM
Income Statements
Fiscal Year end for iBio, Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 2 | 2 | 2 |
Cost Of Goods | 0 | 0 | 0 | 1 | 0 |
Gross Profit | 0 | 0 | 2 | 1 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 17 | 29 | 52 | 32 | 16 |
Income After Depreciation & Amortization | -17 | -29 | -50 | -31 | -14 |
Non-Operating Income | 1 | 0 | 1 | 10 | 0 |
Interest Expense | 0 | 0 | 1 | 2 | 2 |
Pretax Income | -15 | -29 | -50 | -23 | -16 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -15 | -29 | -50 | -23 | -16 |
Extras & Discontinued Operations | -9 | -36 | 0 | 0 | 0 |
Net Income (GAAP) | -25 | -65 | -50 | -23 | -16 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -28 | -45 | -28 | -12 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 4 | 3 | 2 |
Income After Depreciation & Amortization | -17 | -29 | -50 | -31 | -14 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | 3.83 | 0.61 | 0.44 | 0.39 | 0.13 |
Diluted EPS Before Non-Recurring Items | -4.03 | -47.80 | -115.60 | -85.00 | -305.00 |
Diluted Net EPS (GAAP) | -6.50 | -106.20 | -115.60 | -60.00 | -305.00 |
Fiscal Year end for iBio, Inc falls in the month of June .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.18 | 0.00 | 0.00 | 0.05 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.18 | 0.00 | 0.00 | 0.05 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.58 | 3.62 | 4.50 | 5.16 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.40 | -3.62 | -4.50 | -5.11 |
Non-Operating Income | NA | 0.22 | 1.04 | 0.04 | 0.06 |
Interest Expense | NA | 0.06 | 0.05 | 0.03 | 0.03 |
Pretax Income | NA | -3.25 | -2.64 | -4.49 | -5.07 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.25 | -2.64 | -4.49 | -5.07 |
Extras & Discontinued Operations | NA | -4.53 | -0.54 | -3.72 | -0.67 |
Net Income (GAAP) | NA | -7.78 | -3.17 | -8.21 | -5.75 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 3.71 | 1.86 | 1.20 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.71 | -2.42 | -4.20 |
Diluted Net EPS (GAAP) | NA | 3.57 | -0.85 | -4.42 | -4.80 |